Witten, Germany

Eric Ehrke-Schulz

USPTO Granted Patents = 1 

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Eric Ehrke-Schulz: Pioneering Gene Therapy

Introduction: Eric Ehrke-Schulz, an innovative inventor based in Witten, Germany, has made significant contributions to the field of gene therapy. With a patent portfolio showcasing his expertise, he continues to advance medical science through his groundbreaking work.

Latest Patents: Eric holds a patent related to adenoviral vectors. This invention encompasses adenoviral vectors, cells for generating these vectors, methods for their production, and therapeutic applications in gene therapy, tumor therapy, and vaccines. His work in this area has the potential to transform treatment approaches and improve patient outcomes.

Career Highlights: Eric serves at Gene Bridges GmbH, a company dedicated to developing tools for genomic applications. His career at Gene Bridges has positioned him as a leader in the field, contributing to important advancements in biotechnology and gene therapy.

Collaborations: Throughout his career, Eric has collaborated with esteemed colleagues, including Adrian Francis Stewart and Jun Fu. These collaborations highlight the importance of teamwork in driving innovations and achieving successful outcomes in complex research endeavors.

Conclusion: Eric Ehrke-Schulz is a notable figure in the realm of gene therapy, with a patent that reinforces his role as a forward-thinking inventor. His work at Gene Bridges GmbH and collaborations with talented researchers emphasize the valuable contributions he makes toward advancements in medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…